vs
Side-by-side financial comparison of Protagonist Therapeutics, Inc (PTGX) and Resolute Holdings Management, Inc. (RHLD). Click either name above to swap in a different company.
Protagonist Therapeutics, Inc is the larger business by last-quarter revenue ($170.6M vs $117.7M, roughly 1.4× Resolute Holdings Management, Inc.). Protagonist Therapeutics, Inc runs the higher net margin — 77.2% vs -1.5%, a 78.6% gap on every dollar of revenue. Resolute Holdings Management, Inc. produced more free cash flow last quarter ($189.2M vs $182.8M).
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel peptide-based targeted therapies for unmet medical needs, primarily covering gastrointestinal disorders, inflammatory diseases and rare disease indications. Its lead product candidates target inflammatory bowel disease and other chronic immune-related conditions, with operations spanning global R&D and partnership collaborations.
Resolute Mining Limited is an Australian mining corporation focused on mining operations in Africa. It is currently operating two gold mines: the Syama Gold Mine in Mali and the Mako Gold Mine in Senegal.
PTGX vs RHLD — Head-to-Head
Income Statement — Q4 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $170.6M | $117.7M |
| Net Profit | $131.7M | $-1.7M |
| Gross Margin | — | 55.7% |
| Operating Margin | 74.3% | 30.2% |
| Net Margin | 77.2% | -1.5% |
| Revenue YoY | 184.4% | — |
| Net Profit YoY | 381.7% | — |
| EPS (diluted) | $2.01 | $-0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $117.7M | ||
| Q3 25 | — | $120.9M | ||
| Q2 25 | — | $119.6M | ||
| Q1 25 | — | $103.9M | ||
| Q4 24 | $170.6M | — | ||
| Q1 24 | $255.0M | — | ||
| Q3 23 | $0 | — | ||
| Q2 23 | $0 | — |
| Q4 25 | — | $-1.7M | ||
| Q3 25 | — | $-231.0K | ||
| Q2 25 | — | $-611.0K | ||
| Q1 25 | — | $-3.4M | ||
| Q4 24 | $131.7M | — | ||
| Q1 24 | $207.3M | — | ||
| Q3 23 | $-34.1M | — | ||
| Q2 23 | $-38.5M | — |
| Q4 25 | — | 55.7% | ||
| Q3 25 | — | 59.0% | ||
| Q2 25 | — | 57.5% | ||
| Q1 25 | — | 52.5% | ||
| Q4 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | — | 30.2% | ||
| Q3 25 | — | 34.3% | ||
| Q2 25 | — | 34.0% | ||
| Q1 25 | — | 24.7% | ||
| Q4 24 | 74.3% | — | ||
| Q1 24 | 80.9% | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | — | -1.5% | ||
| Q3 25 | — | -0.2% | ||
| Q2 25 | — | -0.5% | ||
| Q1 25 | — | -3.2% | ||
| Q4 24 | 77.2% | — | ||
| Q1 24 | 81.3% | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | — | $-0.20 | ||
| Q3 25 | — | $-0.03 | ||
| Q2 25 | — | $-0.07 | ||
| Q1 25 | — | $-0.39 | ||
| Q4 24 | $2.01 | — | ||
| Q1 24 | $3.26 | — | ||
| Q3 23 | $-0.58 | — | ||
| Q2 23 | $-0.68 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $418.9M | $205.5M |
| Total DebtLower is stronger | — | $169.8M |
| Stockholders' EquityBook value | $675.3M | $6.5M |
| Total Assets | $744.7M | $333.4M |
| Debt / EquityLower = less leverage | — | 26.03× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $205.5M | ||
| Q3 25 | — | $148.0M | ||
| Q2 25 | — | $99.9M | ||
| Q1 25 | — | $71.0M | ||
| Q4 24 | $418.9M | — | ||
| Q1 24 | $322.6M | — | ||
| Q3 23 | $320.8M | — | ||
| Q2 23 | $313.4M | — |
| Q4 25 | — | $169.8M | ||
| Q3 25 | — | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q4 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | — | $6.5M | ||
| Q3 25 | — | $10.8M | ||
| Q2 25 | — | $9.6M | ||
| Q1 25 | — | $8.9M | ||
| Q4 24 | $675.3M | — | ||
| Q1 24 | $560.4M | — | ||
| Q3 23 | $302.1M | — | ||
| Q2 23 | $294.1M | — |
| Q4 25 | — | $333.4M | ||
| Q3 25 | — | $293.2M | ||
| Q2 25 | — | $253.3M | ||
| Q1 25 | — | $214.3M | ||
| Q4 24 | $744.7M | — | ||
| Q1 24 | $629.3M | — | ||
| Q3 23 | $330.0M | — | ||
| Q2 23 | $320.5M | — |
| Q4 25 | — | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q4 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $184.2M | $196.1M |
| Free Cash FlowOCF − Capex | $182.8M | $189.2M |
| FCF MarginFCF / Revenue | 107.1% | 160.8% |
| Capex IntensityCapex / Revenue | 0.8% | 5.8% |
| Cash ConversionOCF / Net Profit | 1.40× | — |
| TTM Free Cash FlowTrailing 4 quarters | $101.7M | $313.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $196.1M | ||
| Q3 25 | — | $59.6M | ||
| Q2 25 | — | $48.9M | ||
| Q1 25 | — | $18.4M | ||
| Q4 24 | $184.2M | — | ||
| Q1 24 | $-27.4M | — | ||
| Q3 23 | $-26.6M | — | ||
| Q2 23 | $-26.2M | — |
| Q4 25 | — | $189.2M | ||
| Q3 25 | — | $58.6M | ||
| Q2 25 | — | $47.5M | ||
| Q1 25 | — | $17.8M | ||
| Q4 24 | $182.8M | — | ||
| Q1 24 | $-27.7M | — | ||
| Q3 23 | $-27.0M | — | ||
| Q2 23 | $-26.4M | — |
| Q4 25 | — | 160.8% | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 39.7% | ||
| Q1 25 | — | 17.1% | ||
| Q4 24 | 107.1% | — | ||
| Q1 24 | -10.9% | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | — | 5.8% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | 0.8% | — | ||
| Q1 24 | 0.1% | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.40× | — | ||
| Q1 24 | -0.13× | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
